More on PSTV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+89.2% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (2/2/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Plus Therapeutics (NQ:PSTV)
Delayed: 0.29 -0.01 (3.33%)
Prev. Close $0.30  
Open$0.30 
52 Wk High$ 
52 Wk Low$ 
Day High$0.30 
Day Low$0.28 
P/E N/A  
EPS$ 
Volume3,178,289 

Friends, Peers and Foes (?): UNH HUM (more...)

Mar 6, 2026 04:06 PM Form RW PLUS THERAPEUTICS, INC.
Feb 27, 2026 04:14 PM Form 4 PLUS THERAPEUTICS, INC. For: Feb 25 Filed by: Sims Andrew John Hugh MacIntyre
Feb 27, 2026 04:11 PM Form 4 PLUS THERAPEUTICS, INC. For: Feb 25 Filed by: HEDRICK MARC H
Feb 25, 2026 07:30 AM Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™
Feb 13, 2026 04:10 PM Form 8-K PLUS THERAPEUTICS, INC. For: Feb 09
Feb 3, 2026 07:26 AM Lake Street Capital Markets Starts Plus Therapeutics Inc. (PSTV) at Buy
Jan 23, 2026 06:43 AM Plus Therapeutics Inc. (PSTV) PT Lowered to $1 at H.C. Wainwright
Jan 22, 2026 10:03 AM Form SCHEDULE 13G PLUS THERAPEUTICS, INC. Filed by: CVI Investments, Inc.
Jan 22, 2026 07:45 AM Plus Therapeutics outlines 2026 goals for REYOBIQ trials and CNSide rollout
Jan 22, 2026 07:45 AM Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
View All Articles

Entities mentioned with PSTV

View All Entities